Rally-Funded Discoveries

$

Sign up for our emails!

Fill out my online form.

Rally-Funded Discoveries

From Rare Disease to Remarkable Discovery: How Rally Helped Launch a New Path for Pediatric Cancer Research

From Rare Disease to Remarkable Discovery: How Rally Helped Launch a New Path for Pediatric Cancer Research

When traditional funding sources weren’t ready to support this high-risk idea, Rally Foundation for Childhood Cancer Research stepped in.  With Rally Foundation’s early funding, Dr. Mark Hatley and his team at St. Jude uncovered a surprising discovery in children with DICER1 cancer predisposition syndrome: A type of white blood cell called a neutrophil may actually help tumors form by releasing harmful web-like structures called neutrophil extracellular traps.  The team...

read more
From Seed Funding to a New Leukemia Drug: How Rally Helped Launch 10+ Years of Discovery

From Seed Funding to a New Leukemia Drug: How Rally Helped Launch 10+ Years of Discovery

Rally Foundation’s early investment in Mark Chiang’s, M.D., Ph.D, lab at the University of Michigan helped generate the preliminary data needed to secure more than $7 million in funding from the National Institutes of Health and over a decade of continuous federal support.  Today, Dr. Chiang’s research is exploring a groundbreaking oral drug, RGT-61159, designed to stop cancer-driving proteins before they even form.  This work could open the door to safer, more targeted treatments for children...

read more
Disrupting Cancer at Its Core: Rally’s Early Investment in Life-Saving Discovery

Disrupting Cancer at Its Core: Rally’s Early Investment in Life-Saving Discovery

In 2018, Muxiang Zhou, MD, at Emory University School of Medicine received early research funding from Rally Foundation for Childhood Cancer Research. That support helped launch discoveries that are bringing new hope to children with hard-to-treat cancers.  Dr. Zhou studies childhood cancer and searches for biomarkers, special clues in the body that show how cancer is growing. His work focuses on creating new medicines for kids with neuroblastoma and acute myeloid leukemia, especially when...

read more
The Power of Starting Early: How One Grant Sparked Lifesaving Leukemia Discoveries

The Power of Starting Early: How One Grant Sparked Lifesaving Leukemia Discoveries

In 2015, Jessica Heath, M.D., at Duke University School of Medicine received early research funding from Rally Foundation for Childhood Cancer Research. That first grant helped launch her career and gave her the chance to study how leukemia begins.  Dr. Heath focused on a protein called CRM1. This protein normally helps cells work the right way. But in leukemia, CRM1 can help cancer grow. Rally’s early support gave her the freedom to ask big questions about how leukemia starts and spreads. ...

read more
Rally-Funded Discovery: Smarter Cell Therapies For Brain Cancer

Rally-Funded Discovery: Smarter Cell Therapies For Brain Cancer

When kids are diagnosed with brain cancer, the treatments can be really tough. That’s why scientists are looking for new ways to help the body fight cancer. One of those scientists is Margarita Gutova, Ph.D., at City of Hope. Thanks to early support from the Rally Foundation for Childhood Cancer Research, Dr. Gutova was able to ask bold questions and explore new ideas.  Fighting Cancer With the Body’s Own Cells  Dr. Gutova studies advanced treatments like CAR T-cell therapy and stem cell...

read more
How Rally’s Support Helped Target a Rare and Aggressive Childhood Leukemia

How Rally’s Support Helped Target a Rare and Aggressive Childhood Leukemia

Cheng-Kui Qu, M.D., Ph.D., a researcher at Emory University, received seed funding from Rally Foundation from 2018-2022. That early and consistent support allowed his lab to make meaningful progress toward developing new treatments for juvenile myelomonocytic leukemia (JMML), a rare and aggressive childhood blood cancer that is difficult to cure.  In 2018, Rally’s funding helped Dr. Qu and his team explore whether a clinically used antipsychotic drug called pimozide might have a therapeutic...

read more

$

Sign up for our emails!

Fill out my online form.